NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinomaXiao-Ping Zhong, Rong Guo, Jie Mei et al.|Cell Death and Disease|2019Cited by 49
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinomaLiang-He Lu, Rong Guo, Yong‐Fa Zhang et al.|Digestive and Liver Disease|2019Cited by 40